Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for IBRX

Stock NameImmunitybio Inc
TickerIBRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45256X1037
LEI529900J9XLBR4HFL4B83

Show aggregate IBRX holdings

News associated with IBRX

HC Wainwright Reaffirms “Buy” Rating for ImmunityBio (NASDAQ:IBRX)
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a note issued to investors on Wednesday,Benzinga reports. They currently have a $8.00 price objective on the stock. HC Wainwright’s price target would indicate a potential upside of 208.88% from the company’s previous close. A number […] - 2025-09-12 03:00:44
D. Boral Capital Reaffirms “Buy” Rating for ImmunityBio (NASDAQ:IBRX)
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $24.00 target price on the stock. IBRX has been the subject of a number of other research reports. HC Wainwright […] - 2025-09-10 02:40:51
Stock Traders Buy High Volume of Call Options on ImmunityBio (NASDAQ:IBRX)
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors bought 18,890 call options on the company. Thisisanincreaseof283% compared to the average volume of 4,932 call options. ImmunityBio Price Performance Shares of IBRX opened at $2.71 on Friday. ImmunityBio has a 1 year low of $1.83 […] - 2025-08-15 02:34:48
ImmunityBio, Inc. (NASDAQ:IBRX) Stake Raised by Zurcher Kantonalbank Zurich Cantonalbank
Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 42.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,992 shares of the company’s stock after acquiring an additional 13,139 shares during the period. […] - 2025-08-11 05:32:50
VBK's Underlying Holdings Could Mean 12% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-28 08:27:30
Crestwood Advisors Group LLC Buys 6,000 Shares of ImmunityBio, Inc. (NASDAQ:IBRX)
Crestwood Advisors Group LLC grew its holdings in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 37.0% during the first quarter, Holdings Channel.com reports. The institutional investor owned 22,200 shares of the company’s stock after purchasing an additional 6,000 shares during the quarter. Crestwood Advisors Group LLC’s holdings in ImmunityBio were worth $67,000 at […] - 2025-07-24 05:48:55
SBI Securities Co. Ltd. Sells 9,900 Shares of ImmunityBio, Inc. (NASDAQ:IBRX)
SBI Securities Co. Ltd. cut its holdings in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 43.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 12,777 shares of the company’s stock after selling 9,900 shares during the period. SBI Securities Co. Ltd.’s […] - 2025-07-21 06:58:48
Xponance Inc. Buys New Stake in ImmunityBio, Inc. (NASDAQ:IBRX)
Xponance Inc. bought a new stake in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 11,021 shares of the company’s stock, valued at approximately $33,000. Several other large investors have also recently made changes to their positions in IBRX. Swiss National […] - 2025-07-21 05:38:57
Cambridge Investment Research Advisors Inc. Acquires Shares of 17,950 ImmunityBio, Inc. (NASDAQ:IBRX)
Cambridge Investment Research Advisors Inc. acquired a new stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The firm acquired 17,950 shares of the company’s stock, valued at approximately $54,000. Several other institutional investors and hedge funds have also bought and sold shares of IBRX. Vanguard Group Inc. […] - 2025-07-16 04:30:59
Vontobel Holding Ltd. Has $48,000 Stake in ImmunityBio, Inc. (NASDAQ:IBRX)
Vontobel Holding Ltd. decreased its stake in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 33.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,000 shares of the company’s stock after selling 8,000 shares during the quarter. Vontobel Holding Ltd.’s holdings in ImmunityBio […] - 2025-07-10 05:02:55
Piper Sandler Upgrades ImmunityBio (NASDAQ:IBRX) to Overweight
ImmunityBio (NASDAQ:IBRX – Get Free Report) was upgraded by investment analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a note issued to investors on Tuesday, Marketbeat.com reports. The firm currently has a $5.00 price target on the stock, up from their previous price target of $4.25. Piper Sandler’s price objective […] - 2025-05-22 02:44:47
D. Boral Capital Reiterates “Buy” Rating for ImmunityBio (NASDAQ:IBRX)
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a note issued to investors on Monday,Benzinga reports. They currently have a $30.00 price objective on the stock. Separately, HC Wainwright reaffirmed a “buy” rating on shares of ImmunityBio in a research note on Monday, May […] - 2025-05-14 05:04:48
ImmunityBio (NASDAQ:IBRX) Given Buy Rating at HC Wainwright
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued on Monday,Benzinga reports. They presently have a $8.00 target price on the stock. HC Wainwright’s price objective suggests a potential upside of 218.73% from the stock’s current price. Separately, D. Boral Capital reissued […] - 2025-05-14 05:04:48
ImmunityBio, Inc. (NASDAQ:IBRX) Stake Reduced by Legal & General Group Plc
Legal & General Group Plc lessened its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 7.8% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 131,364 shares of the company’s stock after selling 11,161 shares during the quarter. Legal & General Group Plc’s holdings in ImmunityBio were worth $336,000 at […] - 2025-05-01 05:24:53
Geode Capital Management LLC Decreases Stock Holdings in ImmunityBio, Inc. (NASDAQ:IBRX)
Geode Capital Management LLC cut its stake in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 0.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,840,918 shares of the company’s stock after selling 5,757 shares during the period. Geode Capital Management LLC’s holdings […] - 2025-04-24 04:58:48
LPL Financial LLC Raises Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX)
LPL Financial LLC grew its position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 67.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 257,449 shares of the company’s stock after buying an additional 103,495 shares during the period. LPL […] - 2025-04-24 04:10:54
Teacher Retirement System of Texas Has $107,000 Stock Position in ImmunityBio, Inc. (NASDAQ:IBRX)
Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 41,742 shares of the company’s stock after acquiring an additional 7,067 shares during the period. […] - 2025-04-03 04:54:52
Comparing ImmunityBio (NASDAQ:IBRX) & Curis (NASDAQ:CRIS)
ImmunityBio (NASDAQ:IBRX – Get Free Report) and Curis (NASDAQ:CRIS – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of recent ratings and […] - 2025-04-02 02:20:51
Stephens Inc. AR Invests $26,000 in ImmunityBio, Inc. (NASDAQ:IBRX)
Stephens Inc. AR acquired a new position in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,090 shares of the company’s stock, valued at approximately $26,000. Several other large […] - 2025-02-18 06:16:55
After Hours Most Active for Jan 27, 2025 : VTWO, NVDA, AAPL, T, QQQ, IBRX, GOOGL, BAC, AA, GAP, BABA, XOM
The NASDAQ 100 After Hours Indicator is up 67.15 to 21,194.43. The total After hours volume is currently 157,887,661 shares traded.The following are the most active stocks for the after hours session: Vanguard Russell 2000 ETF (VTWO) is +0.1 at $91.72, with 9,652,088 shares trad - 2025-01-27 19:24:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) IBRX holdings

DateNumber of IBRX Shares HeldBase Market Value of IBRX SharesLocal Market Value of IBRX SharesChange in IBRX Shares HeldChange in IBRX Base ValueCurrent Price per IBRX Share HeldPrevious Price per IBRX Share Held
2025-11-11 (Tuesday)615,370USD 1,316,892IBRX holding decreased by -12307USD 1,316,8920USD -12,307 USD 2.14 USD 2.16
2025-11-10 (Monday)615,370IBRX holding increased by 1580USD 1,329,199IBRX holding increased by 21826USD 1,329,1991,580USD 21,826 USD 2.16 USD 2.13
2025-11-07 (Friday)613,790USD 1,307,373IBRX holding increased by 6138USD 1,307,3730USD 6,138 USD 2.13 USD 2.12
2025-11-06 (Thursday)613,790IBRX holding increased by 1580USD 1,301,235IBRX holding decreased by -15017USD 1,301,2351,580USD -15,017 USD 2.12 USD 2.15
2025-11-05 (Wednesday)612,210USD 1,316,252IBRX holding increased by 42855USD 1,316,2520USD 42,855 USD 2.15 USD 2.08
2025-11-04 (Tuesday)612,210IBRX holding increased by 1586USD 1,273,397IBRX holding decreased by -106613USD 1,273,3971,586USD -106,613 USD 2.08 USD 2.26
2025-11-03 (Monday)610,624USD 1,380,010IBRX holding decreased by -85488USD 1,380,0100USD -85,488 USD 2.26 USD 2.4
2025-10-31 (Friday)610,624USD 1,465,498IBRX holding increased by 24425USD 1,465,4980USD 24,425 USD 2.4 USD 2.36
2025-10-30 (Thursday)610,624IBRX holding increased by 7930USD 1,441,073IBRX holding decreased by -17446USD 1,441,0737,930USD -17,446 USD 2.36 USD 2.42
2025-10-29 (Wednesday)602,694IBRX holding increased by 3172USD 1,458,519IBRX holding decreased by -88248USD 1,458,5193,172USD -88,248 USD 2.42 USD 2.58
2025-10-28 (Tuesday)599,522USD 1,546,767IBRX holding decreased by -47962USD 1,546,7670USD -47,962 USD 2.58 USD 2.66
2025-10-27 (Monday)599,522USD 1,594,729IBRX holding increased by 113910USD 1,594,7290USD 113,910 USD 2.66 USD 2.47
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IBRX by Blackrock for IE00BYXG2H39

Show aggregate share trades of IBRX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY1,5802.2202.130 2.139USD 3,380 3.13
2025-11-06BUY1,5802.2102.110 2.120USD 3,350 3.14
2025-11-04BUY1,5862.2302.070 2.086USD 3,308 3.15
2025-10-30BUY7,9302.4402.350 2.359USD 18,707 3.17
2025-10-29BUY3,1722.4202.600 2.582USD 8,190 3.17
2025-10-22SELL-6,3282.3602.450 2.441USD -15,447 3.19 Profit of 4,731 on sale
2025-10-20BUY3,1642.4502.490 2.486USD 7,866 3.20
2025-10-17BUY7,9022.4002.520 2.508USD 19,818 3.20
2025-10-15BUY12,5922.5802.600 2.598USD 32,714 3.20
2025-10-03BUY10,8362.5402.750 2.729USD 29,571 3.21
2025-10-02BUY1,5482.5002.520 2.518USD 3,898 3.22
2025-09-30BUY3,0922.4602.570 2.559USD 7,912 3.22
2025-09-26BUY3,0962.5402.550 2.549USD 7,892 3.23
2025-09-25BUY3,0962.4602.470 2.469USD 7,644 3.24
2025-09-24BUY42.5002.650 2.635USD 11 3.24
2025-09-18BUY1,5462.8502.970 2.958USD 4,573 3.24
2025-09-17BUY4,6502.7602.940 2.922USD 13,587 3.25
2025-08-20SELL-6,1842.2602.322 2.316USD -14,321 3.27 Profit of 5,878 on sale
2025-07-30BUY6,1682.5602.670 2.659USD 16,401 3.29
2025-07-17SELL-3,0842.8302.870 2.866USD -8,839 3.32 Profit of 1,412 on sale
2025-07-16BUY9,5542.7502.820 2.813USD 26,875 3.33
2025-07-11SELL-12,1282.8102.950 2.936USD -35,608 3.34 Profit of 4,875 on sale
2025-07-07BUY4,5482.7203.000 2.972USD 13,517 3.35
2025-07-02BUY83,4352.6402.770 2.757USD 230,030 3.36
2025-06-20BUY84,2952.8702.930 2.924USD 246,479 3.37
2025-06-11BUY2,4563.2403.400 3.384USD 8,311 3.39
2025-06-10BUY2,4523.3403.760 3.718USD 9,117 3.39
2025-06-04SELL-1,2302.9302.980 2.975USD -3,659 3.39 Profit of 516 on sale
2025-04-23BUY1,2282.6902.870 2.852USD 3,502 3.66
2025-04-10SELL-9,8082.4602.600 2.586USD -25,363 3.77 Profit of 11,628 on sale
2025-04-08SELL-1,2262.4202.830 2.789USD -3,419 3.80 Profit of 1,240 on sale
2025-04-07SELL-1,2262.7202.940 2.918USD -3,577 3.81 Profit of 1,097 on sale
2025-04-04SELL-6,1352.8302.955 2.942USD -18,052 3.82 Profit of 5,412 on sale
2025-04-01BUY12,5982.9603.260 3.230USD 40,692 3.84
2025-03-31SELL-3,6093.0103.150 3.136USD -11,318 3.85 Profit of 2,594 on sale
2025-03-21BUY31,3762.7102.790 2.782USD 87,288 3.93
2025-03-14SELL-17,6482.8702.980 2.969USD -52,397 4.01 Profit of 18,295 on sale
2025-03-07SELL-2,2023.0003.065 3.059USD -6,735 4.09 Profit of 2,270 on sale
2025-03-04SELL-1,1033.0203.170 3.155USD -3,480 4.14 Profit of 1,087 on sale
2025-02-25BUY2,2023.0303.230 3.210USD 7,068 4.24
2025-02-19SELL-1,0993.9004.270 4.233USD -4,652 4.29 Profit of 62 on sale
2025-02-13BUY3,2913.3203.386 3.379USD 11,122 4.35
2025-02-12BUY1,0973.2403.275 3.272USD 3,589 4.38
2025-02-11BUY4,3883.1703.350 3.332USD 14,621 4.40
2024-12-30SELL-40,5372.6802.760 2.752USD -111,558 4.96 Profit of 89,690 on sale
2024-11-18SELL-18,0755.0105.040 5.037USD -91,044 4.99 Loss of -872 on sale
2024-11-08SELL-1,2055.5705.580 5.579USD -6,723 4.95 Loss of -758 on sale
2024-10-30BUY5,0315.6406.080 6.036USD 30,367 4.54
2024-10-21SELL-1,1943.5503.560 3.559USD -4,249 0.00 Loss of -4,249 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IBRX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-192,309,94613,3015,042,46745.8%
2025-09-181,919,07233,0295,277,72036.4%
2025-09-171,667,4213,0036,284,77826.5%
2025-09-162,056,90619,1045,939,82634.6%
2025-09-152,206,09120,28921,549,95110.2%
2025-09-121,440,23913,0574,683,96830.7%
2025-09-111,805,31233,3435,845,11130.9%
2025-09-102,941,0032,9446,981,66242.1%
2025-09-092,165,8728,20017,547,24912.3%
2025-09-082,646,3253,2856,495,85940.7%
2025-09-051,159,2411,0003,758,45230.8%
2025-09-041,640,93623,778,89743.4%
2025-09-031,473,11903,980,87737.0%
2025-09-021,400,2629004,627,49130.3%
2025-08-291,236,0902003,285,89837.6%
2025-08-281,915,2055,6893,763,65350.9%
2025-08-271,406,23803,407,72841.3%
2025-08-262,596,11105,880,38844.1%
2025-08-251,710,83254,475,71638.2%
2025-08-222,115,8613156,006,14035.2%
2025-08-211,232,35003,307,22637.3%
2025-08-201,636,78304,515,93436.2%
2025-08-192,460,24720,0336,442,63038.2%
2025-08-183,091,87314,3237,823,71139.5%
2025-08-152,303,5452,5796,292,79136.6%
2025-08-142,094,96121,3985,909,48935.5%
2025-08-134,394,69915,58417,092,43725.7%
2025-08-121,561,9481,9184,396,61035.5%
2025-08-111,997,3415304,417,95045.2%
2025-08-081,181,8081,4822,724,13343.4%
2025-08-072,583,2292,1014,753,50854.3%
2025-08-061,378,0523112,324,92359.3%
2025-08-051,885,9294,4813,330,88056.6%
2025-08-042,310,4182,9124,419,65652.3%
2025-08-012,011,5224,0274,196,14647.9%
2025-07-313,009,0948,0964,883,45661.6%
2025-07-301,816,224823,104,72558.5%
2025-07-292,169,15511,0754,197,51951.7%
2025-07-282,991,28741,4164,322,84069.2%
2025-07-254,099,8109,3178,379,55248.9%
2025-07-241,280,8498023,528,88936.3%
2025-07-231,701,92011,0985,437,32731.3%
2025-07-221,165,5444,4972,570,43745.3%
2025-07-212,173,735623,420,35563.6%
2025-07-182,728,40211,5954,197,51465.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.